In hepatocellular carcinoma, ACSL1 promotes the fat metabolism of the tumor and the progression of the disease by catalyzing the ATP-dependent acylation of fatty acids into long-chain acyl CoAs (LCA-CoAs) (41). This evidence concerns the gene ACSL1 and neoplasm.